AI assistant
Sending…
Insight Molecular Diagnostics Inc. — Director's Dealing 2016
Aug 30, 2016
34238_dirs_2016-08-30_8ed19b48-977e-4341-ac2d-59aacf5a4110.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: OncoCyte Corp (OCX)
CIK: 0001642380
Period of Report: 2016-08-29
Reporting Person: BAILEY DON M (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 247001 | Direct |
Footnotes
F1: The shares are held by Mr. Bailey and his wife as co-trustees of a revocable trust, and in such capacity Mr. Bailey and his wife have shared voting and dispositive power over the shares.
More from Insight Molecular Diagnostics Inc.
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 12
Major Shareholding Notification
2026
Feb 12
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Feb 11
Regulatory Filings
2026
Feb 11
Director's Dealing
2025
Nov 13
Interim / Quarterly Report
2025
Nov 10